Abstract

7528Background: Venetoclax (VEN) is highly effective for the treatment of chronic lymphocytic leukemia (CLL). Tumor lysis syndrome (TLS) during VEN initiation is a major risk and management, includ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Risk and prevention strategies can help avert tumor lysis syndrome
Leesha L Barnese
Pharmacy Today | VOL. 22
Leesha L BarneseLeesha L Barnese
01 Jul 2016
A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on Tumor Lysis Syndrome (TLS) Risk and Safety of Outpatient Venetoclax Dose Escalation
Lindsey E Roeker ... Andrew D Zelenetz
Blood | VOL. 142
Lindsey E Roeker, et. al.Lindsey E Roeker ... Andrew D Zelenetz
28 Nov 2023
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia.
Matthew S Davids ... Chaitra Ujjani
American journal of hematology | VOL. 97
Matthew S Davids, et. al.Matthew S Davids ... Chaitra Ujjani
07 Jan 2022
Tumor Lysis Syndrome: Incidence, Mitigation and Management in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice (DEVOTE) across Canada
Versha Banerji ... Carolyn Owen
Blood | VOL. 138
Versha Banerji, et. al.Versha Banerji ... Carolyn Owen
05 Nov 2021
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss.
Margaret Cupit-Link
Journal of Clinical Oncology | VOL. -
Margaret Cupit-LinkMargaret Cupit-Link
23 Jul 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.
Rafal Dziadziuszko ... Witold Rzyman
Journal of Clinical Oncology | VOL. -
Rafal Dziadziuszko, et. al.Rafal Dziadziuszko ... Witold Rzyman
23 Jul 2024
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update.
Megan E Daly ...
Journal of Clinical Oncology | VOL. -
Megan E Daly, et. al.Megan E Daly ...
23 Jul 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
Connor Lynch ... Ralph R Weichselbaum
Journal of Clinical Oncology | VOL. -
Connor Lynch, et. al.Connor Lynch ... Ralph R Weichselbaum
22 Jul 2024
View more papers